Dihydroergotamine (Mesylate)
Overview
Categories
- 7 Antimigraine preparations
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
L-Carnitine's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 0.014 mg/kg | 0.014 (0.014) | As recommended. | IM | Maint, As Req, after 30-60 Min of the Initial Dose |
| 0.014 to 0.029 mg/kg | 0.021 (0.0215) | As recommended. | IM | Initially for Once |
| 0.014 mg/kg | 0.014 (0.014) | As recommended. | SC | Maint, As Req, after 30-60 Min of the Initial Dose |
| 0.014 to 0.029 mg/kg | 0.021 (0.0215) | As recommended. | SC | Initially for Once |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of L-Carnitine is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of L-Carnitine is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
L-Carnitine
Back to top
Manufacturers of
Dihydroergotamine (Mesylate)
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic